Orexin receptor antagonists for delirium prevention: systematic review in cancer

Authors:

Abstract
Orexin receptor antagonists promote sleep by blocking receptors for orexin, a neurotransmitter that maintains wakefulness. Pharmacological interventions for modifying sleep-wake cycle disturbances have recently garnered increased attention for the prevention of delirium, and previous studies have demonstrated the efficacy of melatonin receptor agonists in the prevention of delirium. Orexin receptor antagonists are also a promising intervention to prevent delirium by modifying the sleep-wake cycle, and several studies have examined the efficacy of orexin receptor antagonists, either alone or in combination with ramelteon, in preventing delirium, particularly in acutely ill patients.